The prospective preventative HIV vaccine based on modified poliovirus

被引:0
|
作者
Zhang, Yang-de [1 ]
Lu, Xiao-lin [1 ]
Li, Nian-feng [1 ]
机构
[1] Cent S Univ, Inst Biomed Engn, Changsha 410008, Hunan, Peoples R China
关键词
D O I
10.1016/j.mehy.2006.07.062
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In order to control HIV pandemic, many vaccines are invented. Although none first verified its efficacy in clinic, we hypothesize that HIV vaccine based on poliovirus is potential to develop the promising one, because it can elicit the broad immune response including the main mucosal, humoral and cellular reaction. However, the viral neural virulence is one major concern. The attenuated Sabin strain is a better candidate. White partial poliovirus genes are replaced by HIV antigen genes, the defective interfering particle will fail to produce progeny virions, which may further ensure its security. Although the vaccinal immune efficacy was verified in some similar animal experiments based on poliovirus to express the exogenous genes, more animal and clinical immune trials about HIV-poliovirus chimeric minireplicons are to be carried out and the hypotheses are to be validated. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1258 / 1261
页数:4
相关论文
共 50 条
  • [32] SAFETY OF LIVE ORAL POLIOVIRUS VACCINE AND THE ORIGIN OF HIV INFECTION IN MAN - REPLY
    LECATSAS
    ALEXANDER
    SOUTH AFRICAN MEDICAL JOURNAL, 1990, 77 (01): : 52 - 52
  • [33] Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire
    Hennessey, KA
    Lago, H
    Diomande, F
    Akoua-Koffi, C
    Caceres, VM
    Pallansch, MA
    Kew, OM
    Nolan, M
    Zuber, PLF
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (12): : 2124 - 2128
  • [34] Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman
    Sutter, RW
    Suleiman, AJM
    Malankar, PG
    Mehta, FR
    Medany, MA
    Arif, MAM
    Linkins, RW
    Pallansch, MA
    ElBualy, MS
    Robertson, SE
    JOURNAL OF INFECTIOUS DISEASES, 1997, 175 : S235 - S240
  • [36] IMMUNOGENICITY STUDIES IN ADULTS AND CHILDREN WITH TRYPSIN-MODIFIED INACTIVATED POLIOVIRUS VACCINE
    PIIRAINEN, L
    ROIVAINEN, M
    LITMANEN, L
    ESKOLA, J
    BEUVERY, AC
    HOVI, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 313 - 313
  • [37] Environmental Poliovirus Surveillance during Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Use in Cordoba Province, Argentina
    Mueller, Judith E.
    Bessaud, Mael
    Huang, Q. Sue
    Martinez, Laura C.
    Barril, Patricia A.
    Morel, Viviane
    Balanant, Jean
    Bocacao, Judy
    Hewitt, Joanne
    Gessner, Brad D.
    Delpeyroux, Francis
    Nates, Silvia V.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2009, 75 (05) : 1395 - 1401
  • [38] Inactivated poliovirus vaccine and the final stages of poliovirus eradication
    Hovi, T
    VACCINE, 2001, 19 (17-19) : 2268 - 2272
  • [39] Surveillance for poliovirus vaccine adverse events, 1991 to 1998: Impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine
    Wattigney, WA
    Mootrey, GT
    Braun, MM
    Chen, RT
    PEDIATRICS, 2001, 107 (05) : E83
  • [40] CURRENT ISSUES IN EVALUATING THE EFFICACY OF ORAL POLIOVIRUS VACCINE AND INACTIVATED POLIOVIRUS VACCINE IMMUNIZATION
    PLOTKIN, SA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (12) : 979 - 981